| |
|
|
|
Oncosec Medical
|
|
1.251 -0.039 (-3.023%) |
10/20/2017 3:59pm |
|
Open: |
1.310 |
Pre close: |
1.290 |
Target:
|
1.80
|
|
High: |
1.310 |
Low: |
1.180 |
Resistance:
|
1.54
1.80
|
|
Volume: |
1,570,573 |
Market Cap: |
26.48M |
Support:
|
1.14
0.90
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.25
 |
MACD |
MACD(12,26):
|
0.07  |
|
MA(20): |
1.09 |
Signal(12,26,9): |
0.05 |
|
MA(100): |
1.05 |
Stochastic Oscillator |
%K(14,3):
|
63.67 |
|
MA(250): |
1.21 |
%D(3): |
67.42 |
|
Average Volume(K) |
3-Month: |
21799
|
52-Week |
High:
|
2.08 |
|
10-Days: |
65900 |
Low: |
0.88 |
|
RSI |
RSI(14):
|
62.77 |
Change(%): |
-30.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.140 |
Return on Equity (ttm) |
-110.7 |
Shares Out. (M) |
21.00 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
-57.3 |
Shares Float (M) |
20.41 |
|
EPS Est. Next Year |
-0.980 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.57 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.11 |
|
Forward EPS |
-0.978 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
950 |
|
Book Value (p.s.) |
0.750 |
EBITDA (p.s.) |
-1.035 |
P/E |
-1.10 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.67 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.78 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-9.44 |
P/CF |
-1.57 |
|
|
|
|
|
|
|
